Structure Therapeutics (GPCR) Earnings Date, Estimates & Call Transcripts → Does this make you sick? (From Allegiance Gold) (Ad) Free GPCR Stock Alerts $35.99 +0.17 (+0.47%) (As of 01:18 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 8EstimatedActual EPS (Mar. 8) -$0.17 Beat By $0.04 Consensus EPS (Mar. 8) -$0.21 Get Structure Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for GPCR and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueGPCR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GPCR Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceElon Musk’s Next Move Will Disrupt AI ForeverA revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. Structure Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.20)($0.19)($0.20)Q2 20242($0.20)($0.20)($0.20)Q3 20242($0.21)($0.19)($0.20)Q4 20242($0.24)($0.20)($0.22)FY 20248($0.85)($0.78)($0.82)Q1 20251($0.24)($0.24)($0.24)Q2 20251($0.23)($0.23)($0.23)Q3 20251($0.22)($0.22)($0.22)Q4 20251($0.24)($0.24)($0.24)FY 20254($0.93)($0.93)($0.93)GPCR Earnings Date and InformationStructure Therapeutics last issued its quarterly earnings results on March 8th, 2024. The reported ($0.17) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.21) by $0.04. Structure Therapeutics has generated ($0.77) earnings per share over the last year (($0.77) diluted earnings per share). Earnings for Structure Therapeutics are expected to grow in the coming year, from ($0.98) to ($0.68) per share. Structure Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.Read More Structure Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/8/2024Estimated)------- 3/8/2024Q4 2023($0.21)($0.17)+$0.04($0.17)--11/14/2023Q3 2023($0.22)($0.21)+$0.01($0.21)--8/10/2023Q2 2023($0.19)($0.20)($0.01)($0.20)--5/11/2023Q1 2023($0.34)($0.25)+$0.09($0.25)-- Structure Therapeutics Earnings - Frequently Asked Questions When is Structure Therapeutics's earnings date? Structure Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on GPCR's earnings history. Did Structure Therapeutics beat their earnings estimates last quarter? In the previous quarter, Structure Therapeutics (NASDAQ:GPCR) reported ($0.17) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.21) by $0.04. Learn more on analysts' earnings estimate vs. GPCR's actual earnings. How much profit does Structure Therapeutics generate each year? Structure Therapeutics (NASDAQ:GPCR) has a recorded net income of -$89.62 million. GPCR has generated -$0.77 earnings per share over the last four quarters. What is Structure Therapeutics's EPS forecast for next year? Structure Therapeutics's earnings are expected to grow from ($0.98) per share to ($0.68) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Agios Pharmaceuticals Earnings Date Galapagos Earnings Date Catalyst Pharmaceuticals Earnings Date Harmony Biosciences Earnings Date Syndax Pharmaceuticals Earnings Date Edgewise Therapeutics Earnings Date Schrödinger Earnings Date Supernus Pharmaceuticals Earnings Date Amneal Pharmaceuticals Earnings Date Zai Lab Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:GPCR) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetryThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHe Is Giving Away BitcoinCrypto Swap ProfitsThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsHow Biden has already won 2024Porter & CompanyThe Crypto 9-5 Escape PlanCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Structure Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.